| Future Health Pharma GmbH - Yselty 100 mg, Filmtabletten | | 69692 | | 01 | | Yselty 100 mg | | Filmtabletten | | H01CC04 | | Linzagolix | | 19.01.2026 | | |
| | Composition | | Filmtablette: linzagolixum 100 mg ut linzagolixum cholinum, lactosum monohydricum 125.7 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 1.8 mg, magnesii stearas, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. | informations additionels |
|---|
| Linzagolixum | 100 mg | Filmtablette |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum | | Überzug | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Lactose Monohydrate | 125.7 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 28 | | | B | | Oui | | 002 | 84 | | | B | | Oui |
|
|
